Yizhi Baduanjin for improving cognitive function in patients with mild cognitive impairment
The Validation and Beneficial Effects of Yizhi Baduanjin for Patients With Mild Cognitive Impairment: a Pilot Randomised Controlled Trial
This study is testing if practicing Yizhi Baduanjin can help improve memory and thinking skills in older adults with mild cognitive impairment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 60 Years to 75 Years |
| Sex | All |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06453941 on ClinicalTrials.gov |
What this trial studies
This trial investigates the effects of Yizhi Baduanjin, a traditional Chinese health practice, on patients with mild cognitive impairment (MCI). Thirty participants aged 60 to 75 will be randomly assigned to either the intervention group, which will practice Yizhi Baduanjin, or a control group for six months. The primary outcome will be measured using the Montreal Cognitive Assessment (MoCA), while additional cognitive assessments will also be conducted. The goal is to determine if this non-drug intervention can enhance memory and cognitive function in MCI patients.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 60 to 75 who have been diagnosed with mild cognitive impairment and can complete cognitive assessments.
Not a fit: Patients who are unable or unwilling to learn and practice the Yizhi Baduanjin routine may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could provide a non-pharmaceutical approach to slowing cognitive decline in patients with mild cognitive impairment.
How similar studies have performed: While the specific approach of Yizhi Baduanjin is novel, other non-drug interventions for cognitive impairment have shown promise in previous studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 60 to 75 years old. 2. Voluntarily and sign the informed consent form. 3. Non-handicapped, able to complete the cognitive function examination. 4. Fulfill the diagnostic criteria. 5. Montreal Cognitive Assessment (MoCA )Scale \< 26 Exclusion Criteria: 1. Fail to meet the inclusion criteria. 2. Fail to comply to the requirements, or fail to complete the examination. 3. Unwilling or unable to learn and practice the Yizhi Baduanjin routine.
Where this trial is running
Hong Kong
- The University of Hong Kong — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Zhangjin Zhang, MMed, PhD — The University of Hong Kong
- Study coordinator: Zhangjin Zhang, MMed, PhD
- Email: zhangzj@hku.hk
- Phone: +852 3917 6445
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.